摘要 |
N-terminal substituted dipeptide nitriles are defined. These compounds are useful as inhibitors of cysteine cathepsins, e.g. cathepsins B, K, L and S, and can be used for the treatment of cysteine cathepsin dependent diseases and conditions, including inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis, tumours (especially tumour invasion and tumour metastasis), coronary disease, atherosclerosis (including atherosclerotic plaque rupture and destabilization). Particular dipeptide nitriles are compounds of formula (I), or physiologically-acceptable and -cleavable esters or salts thereof, wherein: the symbols are as defined. In particular it has been found that by appropriate choice of groups R, R2, R3, R4, R5, X1, Y and L, the relative selectivity of the compounds as inhibitors of the various cysteine cathepsin types, e.g. cathepsins B, K, L and S, may be altered, e.g. to obtain inhibitors which selectively inhibit a particular cathepsin type or combination of cathepsin types.
|
申请人 |
NOVARTIS AG |
发明人 |
MISSBACH, MARTIN;SAKAKI, JUNICHI;TAKAI, MICHIHIRO;TENO, NAOKI;COWEN, SCOTT DOUGLAS;GREENSPAN, PAUL DAVID;MCQUIRE, LESLIE WIGHTON;TOMMASI, RUBEN ALBERTO;VAN DUZER, JOHN HENRY;ALTMANN, EVA;BETSCHART, CLAUDIA;GOHDA, KEIGO;HORIUCHI, MIYUKI;LATTMANN, RENE |